John Guandolo is the vice president of Strategic Engagement Group, which earned him the Defender of the Homeland award in 2007. John Guandolo has an interest in contributing to charities and is a supporter of the National Multiple Sclerosis Society.
The National Multiple Sclerosis Society is a charity focused on finding a cure for multiple sclerosis (MS), a disease that affects the central nervous system and can cause severe pain and even blindness and paralysis. The National MS Society makes great strides every year in funding research on the disease.
In 2015, one of the many positive results of the organization’s efforts was the release of the first generic version of the drug Copaxone, a glatiramer acetate injection that is used to treat those with relapsing forms of MS. Distribution of the generic form, known as Glatopa, began in June. The development and distribution of Glatopa will lead to more generics being released in the future, providing individuals who have MS with a less costly form of therapy.